Laboratorios Farmaceuticos Rovi (ROVI)

Index:

IBEX 35

  55.95
   
  • 52 Week High:  82.25
  • 52 Week Low:  42.40
  • Currency: Euro
  • Shares Issued: 51.21m
  • Market Cap:  2,865.20m
  • RiskGrade: 165
  • Beta: 0.48

Financial Analysis

Select chart: EPS | Revenue

Key Fundamentals

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 459.42 75.22 110.00¢ n/a n/a +57% 17.51¢ 0.0%
31-Dec-21 648.68 182.63 276.00¢ 26.7 0.2 +151% 38.12¢ 0.5%
31-Dec-22 817.70 257.97 373.00¢ 9.7 0.3 +35% 95.56¢ 2.7%
31-Dec-23 829.51 220.41 320.00¢ 18.8 n/a -14% 129.38¢ 2.1%
31-Dec-24 763.75 177.69 267.00¢ 23.6 n/a -17% 94.00¢ 1.5%

Forecasts

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 726.51 165.47 251.13¢ 22.3 n/a -6% 94.13¢ 0.0%
31-Dec-26 832.91 214.63 326.13¢ 17.2 0.6 +30% 109.00¢ 0.0%
31-Dec-27 934.00 268.98 411.00¢ 13.6 0.5 +26% 136.83¢ 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 26.74 9.67 n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

ROVI Market Data

Currency Euro
% Change 0.00 %
52 Week High  82.25
52 Week Low  42.40
Shares Issued 51.21m
Market Cap  2,865.20m
Beta 0.48
RiskGrade 165

What The Brokers Say

Strong Buy 2
Buy 4
Neutral 3
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page